Does Cancer Screening Actually Extend Lives?

[MEDPAGE TODAY]( Oncology Update Tuesday, August 29, 2023 [Does Cancer Screening Actually Extend Lives?]( [Teen HPV Vaccine Rates Stall for First Time in a Decade]( [U.S. Unveils First 10 Drugs for Medicare Price Negotiations]( [AI-Aided Colonoscopy Flops for Advanced Neoplasia Detection in Trial]( [Cancer Therapy's Lower-Limb Blood Clots Better Treated With Long Anticoagulation]( ADVERTISEMENT Exclusives & Features [Can COVID, Flu, and RSV Shots Be Given at the Same Time?]( [Company Selling Unproven Insulin Infusions in Legal Battle Over Money, Control]( [Who Should Get a COVID Booster This Fall?]( [Circulating metabolites and physical performance are predictors of overall survival in metastatic lung cancer patients]( Background: Skeletal muscle atrophy and low physical performance are associated with disease progression and higher mortality rates in multiple pathological conditions. Here, we determined whether... [READ MORE]( [Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia.]( The addition of cladribine, or sorafenib to standard chemotherapy have each demonstrated improved survival in patients with newly-diagnosed acute myeloid leukemia (AML). We studied the combination of... [READ MORE]( [Circulating Tumor Cells are an Independent Risk Factor for Poor Prognosis in Patients with Gallbladder Adenocarcinoma.]( BACKGROUND: The study aimed to evaluate the prognostic impact of circulating tumor cells (CTCs) in patients with gallbladder adenocarcinoma after resection.MATERIALS AND METHODS: Between January 2018... [READ MORE]( [Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer.]( BACKGROUND: We characterized the risk factors and survival of metastatic breast cancer (MBC) patients with brain metastases (BrM) as the first and only site of disease in a large, retrospective... [READ MORE]( [MITF E318K: A rare homozygous case with multiple primary melanoma.]( MITF E318K moderates melanoma risk. Only five MITF E318K homozygous cases have been reported to date, one in association with melanoma. This novel report uses 3D total-body-photography (TBP) to... [READ MORE]( [A Property of Everyday Health group]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2023-08-29&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011